![Information](/productperformance-static/images/infow.png)
Device Survival Probability
VIRTUOSO_II_VR_SURV
1 yr | 2 yr | 3 yr | 4 yr | 5 yr | 6 yr | 7 yr | 8 yr | 9 yr | 10 yr | 11 yr | 12 yr | 13 yr | at 157.0 mo | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% | ![]() |
100.0 | 100.0 | 99.9 | 99.9 | 99.9 | 99.8 | 99.7 | 99.7 | 99.7 | 99.5 | 99.5 | 99.5 | 99.5 | 99.5 | |||||||
% | ![]() |
99.7 | 99.7 | 99.4 | 99.2 | 98.8 | 98.3 | 96.8 | 92.0 | 80.8 | 56.7 | 47.6 | 46.2 | 45.3 | 45.3 | |||||||
# | 7678 | 7160 | 6653 | 6136 | 5663 | 5130 | 4569 | 3747 | 2497 | 1295 | 885 | 687 | 182 | 130 |
- Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
- Excluding Normal Battery Depletion – This is the malfunction free survival curve.
![Information](/productperformance-static/images/infow.png)
Product Characteristics
Generator Type | ICD |
---|---|
NBD Code | VVE-VVIR |
Max. Delivered Energy | 35 J |
Connector Style | Cx Style |
---|---|
Serial Number Prefix | PZQ |
Mass | 68 g |
Volume | 37 cc |
Waveform | Biphasic |
X-Ray ID | PUG |
![](/productperformance-static/images/connector-cx.gif)
![Information](/productperformance-static/images/infow.png)
Estimated Longevity
Charging Frequency | 100% Pacing | 50% Pacing | 15% Pacing | 100% Sensing |
---|---|---|---|---|
Monthly | 4.3 | 4.7 | 4.9 | 5.0 |
Quarterly | 6.7 | 7.5 | 8.1 | 8.4 |
Semi-annual | 7.8 | 8.9 | 9.8 | 10.3 |
Longevity estimates based on the following device usage. Pacing Mode VVI; Ventricular Lower Pacing Rate 60ppm; Ventricular Pulse Width 0.4ms; Ventricular Pulse Amplitude 3V; Ventricle Impedance 510ohms; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Optivol ON; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formation. Hide this content
![Information](/productperformance-static/images/infow.png)
Distribution Data
US Market Release | |
---|---|
CE Approval Date | 2008-08-20 |
Registered USA Implants | |
Estimated Active USA Implants | |
Normal Battery Depletions |
US Market Release | |
---|---|
CE Approval Date | 2008-08-20 |
Estimated WW Distribution | 6872 |
Normal Battery Depletions | 6 |
![Information](/productperformance-static/images/infow.png)
EOS Indication
The Prolonged Service Period (PSP) is the time between the RRT and EOS. The PSP is defined as 3 months assuming the following conditions: 100% VVI pacing at 60 min-1, 2.5 V RV pacing amplitude; 0.4 ms pulse width; 600 Ω pacing load; and 6 full-energy charges. The EOS may be indicated before the end of 3 months if the device exceeds these conditions.
Data as of December 1, 2023